Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1996
12/19/1996CA2288401A1 Icam-4 materials and methods
12/19/1996CA2226463A1 Recombinational cloning using engineered recombination sites
12/19/1996CA2224232A1 Methods, kits, and compositions for diagnosing papillomavirus infection
12/19/1996CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224174A1 Method for obtaining receptor agonist antibodies
12/19/1996CA2224172A1 Use of gram-positive bacteria to express recombinant proteins
12/19/1996CA2224144A1 Method of transferring at least two saccharide units with a polyglycosyltransferase
12/19/1996CA2224114A1 Synthetic mammalian chromosome and methods for construction
12/19/1996CA2224104A1 Recombinant production of novel polyketides
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996CA2224014A1 3' utr of the human prohibitin gene
12/19/1996CA2224012A1 Developmentally-regulated endothelial cell locus-1
12/19/1996CA2224004A1 Transgenic plants co-expressing a functional human 2-5a system
12/19/1996CA2223980A1 Chondroitinase production in recombinant proteus vulgaris strains
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223934A1 Separation of active complexes
12/19/1996CA2223928A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223923A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223891A1 Treatment of insulin resistance
12/19/1996CA2223832A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996CA2223775A1 Internal positive controls for nucleic acid amplification
12/19/1996CA2223774A1 Detection of nucleic acids by formation of template-dependent product
12/19/1996CA2223771A1 Catalytic dna
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/19/1996CA2223637A1 A method of transfection of cells using liposomally encapsulated nucleic acids
12/19/1996CA2223611A1 Appetite regulating compositions
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2223591A1 Recombinant fowlpox viruses and uses thereof
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2223527A1 Linked linear amplification of nucleic acids
12/19/1996CA2223519A1 Methods for evaluation of antimicrobial targets
12/19/1996CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
12/19/1996CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996CA2223494A1 Chromosomal expression of heterologous genes in bacterial cells
12/19/1996CA2223493A1 Recombinant viral nucleic acids
12/19/1996CA2223459A1 Regulatory elements conferring tapetum specificity
12/19/1996CA2223454A1 Molecular methods of hybrid seed production
12/19/1996CA2223440A1 Fucosyltransferase genes and uses thereof
12/19/1996CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
12/19/1996CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons)
12/19/1996CA2223277A1 Method for detection of antibody to hepatitis c virus second envelope glycoprotein
12/19/1996CA2223275A1 High affinity nucleic acid ligands to lectins
12/19/1996CA2223246A1 Cell line producing analgesic compounds for treating pain
12/19/1996CA2223183A1 Anchor libraries and identification of peptide binding sequences
12/19/1996CA2223181A1 Adenosine kinase polynucleotides
12/19/1996CA2223179A1 Phosphonic acid-based cationic lipids
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
12/19/1996CA2223104A1 Pcr-based cdna subtractive cloning method
12/19/1996CA2223086A1 Novel serpin derived from human hypothalamus
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2223050A1 Probe masking method of reducing background in an amplification reaction
12/19/1996CA2223041A1 Immunological combination compositions and methods
12/19/1996CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996CA2223003A1 High-affinity nucleic acid ligands of cytokines
12/19/1996CA2222999A1 Novel ctla4/cd28 ligands and uses therefor
12/19/1996CA2222947A1 Inhibin compositions and methods of enhancing production performance
12/19/1996CA2222941A1 A cytotoxicity-based genetic selection system (toxsel)
12/19/1996CA2222793A1 Optimized minizymes and miniribozymes and uses thereof
12/19/1996CA2222789A1 Bone stimulating factor
12/19/1996CA2222761A1 Recombinant bacterial system with environmentally limited viability
12/19/1996CA2222586A1 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996CA2222574A1 Oral delivery of adeno-associated viral vectors
12/19/1996CA2222562A1 Method for screening for receptor agonists and antagonists
12/19/1996CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell
12/19/1996CA2222534A1 In vitro packaging of adeno-associated virus dna
12/19/1996CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna
12/19/1996CA2222510A1 Template and primer based synthesis of enzymatically cleavable oligonucleotides
12/19/1996CA2222305A1 Nucleic acid probes and amplification oligonucleotides for neisseria species
12/19/1996CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222174A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996CA2222134A1 Monospecific antibodies against a subunit of fibrinogen
12/19/1996CA2221986A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996CA2221821A1 Endothelial-monocyte activating polypeptide iii
12/19/1996CA2221747A1 Cotton fiber transcriptional factors
12/19/1996CA2221726A1 Use of ovary-tissue transcriptional factors
12/19/1996CA2221710A1 Gene therapy for myocardial ischemia
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221602A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus
12/19/1996CA2221521A1 Male infertility y-deletion detection with multiplex primer combinations
12/19/1996CA2221480A1 Mutants of streptococcal toxin a and methods of use
12/19/1996CA2221240A1 Controlling hemipteran insect pests with bacillus thuringiensis
12/19/1996CA2221193A1 Chondroitinase i and chondroitinase ii producing mutants of p. vulgaris
12/19/1996CA2220957A1 Glycine and phaseolus .alpha.-d-galactosidases
12/19/1996CA2220952A1 Anti-allergy bispecific molecules
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996CA2220459A1 Expression of functional vertebrate phospholipases in yeast
12/19/1996CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same
12/19/1996CA2196972A1 Repellent compositions containing flavonoid aldehydes